[NKTR] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -109.90%
YoY- -257.95%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 24,921 30,033 29,218 27,762 152,928 36,336 59,952 -13.59%
PBT -129,594 -108,565 -98,486 -97,043 61,073 -43,085 -8,111 58.63%
Tax 112 21 322 -900 202 139 92 3.32%
NP -129,706 -108,586 -98,808 -96,143 60,871 -43,224 -8,203 58.36%
Tax Rate - - - - -0.33% - - -
Total Cost 154,627 138,619 128,026 123,905 92,057 79,560 68,155 14.61%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -520.47 -361.56 -338.18 -346.31 39.80 -118.96 -13.68 83.29%
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -0.70 -0.61 -0.56 -0.56 0.39 -0.32 -0.06 50.54%
EPS Diluted -0.70 -0.61 -0.56 -0.56 0.37 -0.32 -0.06 50.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.